advertisement
Van de Velde S 5
Showing records 1 to 5 | Display only abstracts from Van de Velde S in IGR 16-161357 Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics
Van de Velde S; De Groef L; Stalmans I; Moons L; Van Hove I
Progress in Neurobiology 2015; 131: 105-119 (IGR: 17-1)
60278 Vascular dysregulation in normal-tension glaucoma is not affected by structure and function of the microcirculation or macrocirculation at rest: a case-control study
Bossuyt J; Vandekerckhove G; De Backer TL; Van de Velde S; Azermai M; Stevens AM; Kestelyn P; Raemdonck T; Segers P; Vanmolkot F; Van Bortel LM
Medicine 2015; 94: e425 (IGR: 16-4)
56207 AMA0076, a novel, locally acting Rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia
Van de Velde S; Van Bergen T; Sijnave D; Hollanders K; Castermans K; Defert O; Leysen D; Vandewalle E; Moons L; Stalmans I
Investigative Ophthalmology and Visual Science 2014; 55: 1006-1016 (IGR: 16-1)
56636 Improving patient outcomes following glaucoma surgery: state of the art and future perspectives
Van Bergen T; Van de Velde S; Vandewalle E; Moons L; Stalmans I
Clinical Ophthalmology 2014; 8: 857-867 (IGR: 16-1)
55192 Inhibition of placental growth factor improves surgical outcome of glaucoma surgery
Van Bergen T; Jonckx B; Hollanders K; Sijnave D; Van de Velde S; Vandewalle E; Moons L; Stassen JM; Stalmans I
Journal of cellular and molecular medicine 2013; 17: 1632-1643 (IGR: 15-4)
